2025. Use of Dipeptidyl Peptidase 4 (DPP4) Inhibitors in Diabetic Nephropathy: A Prospective Cohort Study. Medical Forum Monthly. 36, 9 (Oct. 2025). DOI:https://doi.org/10.60110/medforum.360904.